CN1056078C - Traditional Chinese Medicine- - Google Patents

Traditional Chinese Medicine- Download PDF

Info

Publication number
CN1056078C
CN1056078C CN96119199A CN96119199A CN1056078C CN 1056078 C CN1056078 C CN 1056078C CN 96119199 A CN96119199 A CN 96119199A CN 96119199 A CN96119199 A CN 96119199A CN 1056078 C CN1056078 C CN 1056078C
Authority
CN
China
Prior art keywords
radix
rhizoma
prescription
thick paste
flos caryophylli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN96119199A
Other languages
Chinese (zh)
Other versions
CN1184649A (en
Inventor
陈蔚文
幸而
叶富强
廖彩震
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Qingyun Mountain Pharmaceutical Co., Ltd.
Guangzhou University of Chinese Medicine
Original Assignee
QINGYUNSHAN TRADITIONAL CHINESE MEDICINE PLANT WENGYUAN COUNTY GUANGDONG PROV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QINGYUNSHAN TRADITIONAL CHINESE MEDICINE PLANT WENGYUAN COUNTY GUANGDONG PROV filed Critical QINGYUNSHAN TRADITIONAL CHINESE MEDICINE PLANT WENGYUAN COUNTY GUANGDONG PROV
Priority to CN96119199A priority Critical patent/CN1056078C/en
Publication of CN1184649A publication Critical patent/CN1184649A/en
Application granted granted Critical
Publication of CN1056078C publication Critical patent/CN1056078C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to a Weichangshu which is a drug for medicinal treatment to cure patients with liver-stomach disharmonious diseases, such as gastric ulcer, duodenal ulcer and chronic gastritis, and a preparation method of the drug. Nine plant drugs of coptis, rhubarb, etc. are taken to form the formula, and advanced preparation processes are adopted which comprise: volatilization adopts the technique of inclusion compound; heating technology is replaced with decompress concentrating and drying at a low temperature; quality control process adopts monitoring berberine hydrochloride in the coptis, and more than half of the drugs in the formula. The medicine of the present invention has good therapeutic effect, less side effect, convenient sources of raw materials, no poison by clinic verification and no discovered toxic or side effect.

Description

A kind of stomach function regulating analgesic
The present invention relates to a kind of medical Chinese patent medicine, particularly a kind of Chinese patent medicine that derives from vegetable drug.
Stomach, duodenal ulcer and chronic gastritis are common frdquently encountered disease, and sickness rate has the trend that progressively raises.Wherein see with liver-stomach disharmony type especially, and often double gas enclosure stagnates, blood stasis or hot and suffocating more.In the prior art, the new Chinese medicine of establishing, having better curative effect at above disease liver-stomach disharmony type patient is more rare, and curative effect is relatively poor.
Purpose of the present invention is intended to avoid the deficiencies in the prior art and a kind of pharmaceutical drugs that stomach, duodenal ulcer and chronic gastritis belong to the liver-stomach disharmony type patient that solves---stomach function regulating analgesic is provided.
The object of the present invention is achieved like this:
A kind of stomach function regulating analgesic is characterized in that being made by Rhizoma Coptidis, Radix Et Rhizoma Rhei, Fructus Amomi, Fructus Evodiae, Herba Taraxaci, Flos Caryophylli, Radix Bupleuri, the Radix Aucklandiae and Rhizoma Corydalis vegetable drug, and prescription by weight percentage is as 1. Rhizoma Coptidis 11-16 Fructus Evodiae 5-8 Radix Bupleuri 11-16
Radix Et Rhizoma Rhei 11-16 Herba Taraxaci 11-16 Radix Aucklandiae 10-15
Fructus Amomi 6-10 Flos Caryophylli 2-6 Rhizoma Corydalis 11-16
2. Rhizoma Coptidis, Fructus Evodiae, the Radix Aucklandiae, Rhizoma Corydalis four Chinese medicine material in will filling a prescription, the 30-60 minute post-heating of acetum dipping that adds 0.2-0.7% extracts 2-3 time, and it is the thick paste 1 of 1.30-1.35 that medical filtration, concentrating under reduced pressure must be measured relative density at 80 ℃;
3. Flos Caryophylli, Fructus Amomi two flavors in will filling a prescription, heating decocts 2-3 time and collects volatile oil, and beta-cyclodextrin inclusion compound is used in the oil dehydration, and is standby;
4. Radix Bupleuri, Herba Taraxaci, Radix Et Rhizoma Rhei three flavors add deionized water dipping 30-60 minute in will filling a prescription, and heating decocts 2-3 time, filter to merge Flos Caryophylli group filtrate, and it is the thick paste 2 of 1.28-1.36 that concentrating under reduced pressure must be measured relative density at 80 ℃;
Thick paste 1, thick paste 2 merging are added appropriate amount of starch and stir at 40 ℃-60 ℃, behind the vacuum drying, pulverize, sieve, powder gets dry extract;
Add the appropriate amount of starch mixing again with Benexate Hydrochloride and dried cream powder, the 0-2 capsule or be pressed into tablet of packing into.
The invention will be further described with embodiment with reference to the accompanying drawings below;
Accompanying drawing 1 is a process chart of the present invention.
Embodiment: choose four Chinese medicine materials such as Rhizoma Coptidis 250 grams, Fructus Evodiae 120 grams, the Radix Aucklandiae 230 grams, Rhizoma Corydalis 250 grams, add 0.5% acetum dipping after 45 minutes, the heating extraction secondary, 2 hours for the first time, 1.5 hours for the second time, medical filtration, concentrating under reduced pressure get thick paste 1 (relative density 1.30-1.35,80 ℃).Choose Flos Caryophylli 75 grams, Fructus Amomi 150 grams two flavors, heating decocts secondary, 2 hours for the first time, also collect volatile oil 1.5 hours second time, and leaching secondary medicinal liquid is incorporated Radix Bupleuri group extracting solution into and concentrated, and continue to collect volatile oil 2.5 hours, β-CDBao He is used in the oil dehydration, and is standby; Choose Radix Bupleuri 250 grams, Herba Taraxaci 250 grams, Radix Et Rhizoma Rhei 250 grams three flavors, add dried up dipping 45 minutes, heating decocts secondary, 2 hours for the first time, 1.5 hours for the second time, filter merging Flos Caryophylli group filtrate, concentrating under reduced pressure gets thick paste 2 (relative density 1.30-1.35,80 ℃).Two groups of thick pastes are added appropriate amount of starch stir, behind the vacuum drying (50 ℃), pulverize, cross 40 mesh sieves, powder gets dry extract.With dried cream powder, beta-CD inclusion and appropriate amount of starch mixing in No. 0 capsule of packing into or be pressed into tablet, make 1000 (sheets), promptly get stomach function regulating acesodyne capsule or tablet.
The present invention's advantage compared with prior art is; Good effect, few side effects, raw material sources Convenient, preparation technology advanced person, quality control are tight.
1, proves through Traditional Chinese Medicine University Of Guangzhou's pharmacodynamics test; To acute gastric mucosal lesion, anxious, The chronic gastric ulcer disease has obvious preventive and therapeutic effect, can gastric acid secretion inhibiting. Through clinical verification and Stomach and alleviating pain treatment group total effective rate reaches 92.93%, and the control group total effective rate is 81.67 %. High more than 10% with stomach and alleviating pain clinical efficacy contrast group, two groups there were significant differences. Level is in a leading position in the similar drug.
2, Weichangshu toxicological test result shows that medicine is substantially nontoxic, in the clinical application process not Find toxic and side effect.
3, raw material sources are convenient, and the prescription Chinese medicine all has the drug standards, all record " in State's pharmacopeia " in nineteen ninety-five one one of the version, general medicinal material company all can purchase.
4, preparation technology advanced person; Volatile oil of the present invention adopts the inclusion compound technology, changes tradition Packing or compressing tablet before spray in the particle, be conducive in the storage process to reduce the loss of volatile oil; Process using reduced pressure concentration and low temperature drying that production process need to heat have reduced temperature to having The destruction of effect composition. Preparation process is stable, and can reach more than 2 years stationary phase.
5, quality control is tight; The present invention the prescription in monarch drug in a prescription---the coptis is major control Medicine is measured content of berberine hydrochloride wherein. And the total amount of having determined nearly to write out a prescription is over half Medicinal material differentiate.
The present invention's medicine has clearing liver and stomach, falls the contrary effect that presses down acid, regulating qi-flowing for relieving pain. Be suitable for Epigastric distending pain due to the liver-stomach disharmony, or pain connects two sides of body, warm tongue acid, noisy, the dry mouth Wait bitterly for disease. Also can be used for gastric and duodenal ulcer, chronic gastritis and other illness see have above-mentioned Symptom belongs to the treatment of liver-stomach disharmony.

Claims (1)

1, a kind of stomach function regulating analgesic, it is characterized in that being made by Rhizoma Coptidis, Radix Et Rhizoma Rhei, Fructus Amomi, Fructus Evodiae, Herba Taraxaci, Flos Caryophylli, Radix Bupleuri, the Radix Aucklandiae and Rhizoma Corydalis vegetable drug, prescription by weight percentage is as 1. Rhizoma Coptidis 11-16 Fructus Evodiae 5-8 Radix Bupleuri 11-16
Radix Et Rhizoma Rhei 11-16 Herba Taraxaci 11-16 Radix Aucklandiae 10-15
Fructus Amomi 6-10 Flos Caryophylli 2-6 Rhizoma Corydalis 11-16
2. with Rhizoma Coptidis, Fructus Evodiae, the Radix Aucklandiae, Rhizoma Corydalis four Chinese medicine material in the prescription, the 30-60 minute post-heating of acetum dipping that adds 0.2-0.7% extracts 2-3 time, and it is the thick paste 1 of 1.30-1.35 that medical filtration, concentrating under reduced pressure must be measured relative density at 80 ℃;
3. with Flos Caryophylli, Fructus Amomi two flavors in the prescription, heating decocts 2-3 time and collects volatile oil, and beta-cyclodextrin inclusion compound is used in the oil dehydration, and is standby;
4. with Radix Bupleuri, Herba Taraxaci, Radix Et Rhizoma Rhei three flavors in the prescription, add deionized water dipping 30-60 minute, heating decocts 2-3 time, filters to merge Flos Caryophylli group filtrate, and it is the thick paste 2 of 1.28-1.36 that concentrating under reduced pressure must be measured relative density at 80 ℃;
Thick paste 1, thick paste 2 merging are added appropriate amount of starch and stir at 40 ℃-60 ℃, behind the vacuum drying, pulverize, sieve, powder gets dry extract;
Add the appropriate amount of starch mixing again with Benexate Hydrochloride and dried cream powder, the 0-2 capsule or be pressed into tablet of packing into.
CN96119199A 1996-12-13 1996-12-13 Traditional Chinese Medicine- Expired - Fee Related CN1056078C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96119199A CN1056078C (en) 1996-12-13 1996-12-13 Traditional Chinese Medicine-

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96119199A CN1056078C (en) 1996-12-13 1996-12-13 Traditional Chinese Medicine-

Publications (2)

Publication Number Publication Date
CN1184649A CN1184649A (en) 1998-06-17
CN1056078C true CN1056078C (en) 2000-09-06

Family

ID=5125645

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96119199A Expired - Fee Related CN1056078C (en) 1996-12-13 1996-12-13 Traditional Chinese Medicine-

Country Status (1)

Country Link
CN (1) CN1056078C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102973629B (en) * 2012-10-31 2014-10-22 河南牧翔动物药业有限公司 Oral liquid for preventing and treating intestinal diseases of livestock and poultry and preparation method thereof
CN110624072A (en) * 2019-07-29 2019-12-31 洪光富 A Chinese medicinal composition for treating duodenal ulcer, gastric erosion, gastric perforation, and superficial gastritis, and its preparation method
CN115137706B (en) * 2022-04-06 2023-11-17 重庆希尔安药业有限公司 Industrial preparation method of stomach-harmonizing pain-relieving capsule

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
《中国中西医结合脾胃杂志》1996(1) 1996.1.30 周德端等,幽胃康治疗幽门螺杆菌阳性胃病的研究 *
《新医学》1991,32(7) 1991.7.30 徐建国等,"清幽汤"治疗幽门弯曲菌阳性的胃炎及溃疡病疗效观察;《中国中西医结合脾胃杂志》1996(1) 1996.1.30 周德端等,幽胃康治疗幽门螺杆菌阳性胃病的研究 *
《新医学》1991,32(7) 1991.7.30 徐建国等,"清幽汤"治疗幽门弯曲菌阳性的胃炎及溃疡病疗效观察 *

Also Published As

Publication number Publication date
CN1184649A (en) 1998-06-17

Similar Documents

Publication Publication Date Title
CN109223637B (en) Compound traditional Chinese medicine subprostrate sophora toothpaste and preparation method thereof
CN113616721A (en) Pharmaceutical composition for treating oral ulcer and preparation method and application thereof
CN1056078C (en) Traditional Chinese Medicine-
CN1951453A (en) Chinese medicinal granule for treating piles and preparation method thereof
CN101628053A (en) Chinese herbal medicament used to treat painful swollen gum caused by intense stomach fire
CN101982194B (en) Coptis root compound preparation for treating dampness-heat spleen encumbering type diabetes
CN101327293B (en) Capsules for treating peptic ulcer and preparation method thereof
CN1091383C (en) Process of powder for bath from natural plants
CN102755519B (en) Kudzuvine root-kudzuvine flower anti-canker sore particle and preparation method thereof
CN102671036B (en) Traditional Chinese medicine oral liquid for treating chronic lung abscess and preparing method thereof
CN1827138A (en) Chinese medicine composition prescription for treating cardiovascular and cerebrovascular diseases and preparation technique thereof
CN1314434C (en) Heat-clearing and detoxic medicine and its preparation method
CN1175879C (en) Medicine for curing pain syndrome of late cancer and its preparation
CN1723943A (en) Preparation method of traditional Chinese medicine composition for treating gastritis and peptic ulcer
CN1397321A (en) Prescription and preparing process for compound spanishneedles ointment
CN1759871A (en) Hemostasis capsule and preparation technique
CN1618439A (en) Broad-specturm medicine for treating snake venom poisoning
CN106138494B (en) Kidney nourishing composition and production method thereof
CN114129684B (en) Traditional Chinese medicine composition and preparation method and application thereof
CN1057227C (en) Oral liquid for removing intense heat from throat and preparing process thereof
CN108186874B (en) A Chinese medicinal composition for treating diabetes
CN1038212A (en) The preparation method of " Ai-Ning " (caner meprobamate) injection
CN109157632B (en) Formula and preparation method of granules for treating epigastric pain
CN1245997C (en) Suction stick for reducing fever, relieving sore-throat and anti diarrhea
CN1506085A (en) Chinese goldthread soft capsule for clearing away adverse lung energy and its prepn process

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: GUANGZHOU UNIVERSITY OF TRADITIONAL CHINESE MEDIC

Free format text: FORMER OWNER: NONE

Effective date: 20040604

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20040604

Address after: 512600 Guangdong County of Wengyuan Province Long Xian Zhen Chao Yang Road No. 127

Co-patentee after: Guangzhou University of Chinese Medicine

Patentee after: Qingyunshan Traditional Chinese Medicine Plant, Wengyuan County, Guangdong Prov.

Address before: Seven, building 100, high tech center building, No. 38 martyrs Middle Road, Guangdong, Guangzhou Province, China 512600

Patentee before: Qingyunshan Traditional Chinese Medicine Plant, Wengyuan County, Guangdong Prov.

ASS Succession or assignment of patent right

Owner name: GUANGDONG QINGYUNSHAN MEDICINE CO.,LTD.; GUANGZHO

Free format text: FORMER OWNER: QINGYUNSHAN TRADITIONAL CHINESE MEDICINE FACTORY, WENGYUAN COUNTY, GUANGDONG PROVINCE; GUANGZHOU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE

Effective date: 20080808

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20080808

Address after: Guangdong Xian County of Wengyuan Province Dragon Ring Road No. 369 zip code: 512600

Co-patentee after: Guangzhou University of Chinese Medicine

Patentee after: Guangdong Qingyun Mountain Pharmaceutical Co., Ltd.

Address before: 127 Chaoyang Road, Longxian Town, Wengyuan County, Guangdong Province, zip code: 512600

Co-patentee before: Guangzhou University of Chinese Medicine

Patentee before: Qingyun Mountain pharmaceutical factory, Wengyuan County, Guangdong

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20000906

Termination date: 20151213

EXPY Termination of patent right or utility model